Research Library · Category

Metabolic & Incretin Peptides

Metabolic research compounds are studied for their action on incretin and amylin pathways — including GLP-1, GIP, and glucagon receptor signaling — central to glucose- and energy-metabolism research.

5 compoundsPathway GLP-1, GIP, glucagon, and amylin signalingResearch Use Only

01Compounds in This Category

02How These Are Studied

Compounds in this category are grouped by their association with GLP-1, GIP, glucagon, and amylin signaling. Classification reflects the primary research pathway each compound is studied within; many are also evaluated across adjacent mechanisms. Selection for any research model depends on the specific question, system, and endpoints under study.

All are supplied strictly for laboratory research and are not for human or veterinary use.

03FAQ

What are metabolic & incretin peptides?

Metabolic research compounds are studied for their action on incretin and amylin pathways — including GLP-1, GIP, and glucagon receptor signaling — central to glucose- and energy-metabolism research.

Which compounds are in the metabolic category at Ethos Bio?

This category includes TZ2, Semaglutide, R3, Cagrilintide, AOD-9604. Each is analyzed by an independent third-party laboratory (MZ Biolabs) on a five-point panel with a batch-specific Certificate of Analysis.

How are these compounds tested?

Every lot is tested by MZ Biolabs (Arizona) on a five-point panel — HPLC purity, mass-spec identity, endotoxin, heavy metals, and sterility — with a batch-specific Certificate of Analysis provided per order.

See how every lot is tested → · Compare compounds →